The failed Senate vote was a setback for the bill, which aims to punish the court for its decision to prosecute top Israeli ...
NEW YORK - SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), a biopharmaceutical company with a market capitalization of $81 million engaged in developing cancer therapies, has announced a registered ...